Andrew D Lawrence Selected Research

Andrew D Lawrence Research Topics

19	Parkinson Disease (Parkinson's Disease) 01/2019 - 02/2003
5	Disruptive, Impulse Control, and Conduct Disorders (Kleptomania) 12/2015 - 09/2009
3	Gambling (Pathological Gambling) 01/2013 - 04/2010
2	Cognitive Dysfunction 03/2016 - 12/2013
2	Mania (Manias) 06/2011 - 04/2004
2	Bulimia (Binge Eating) 04/2011 - 04/2010
1	Dementia (Dementias) 03/2016
1	Vomiting 03/2016
1	Nausea 03/2016
1	Obesity 10/2014
1	Hyperphagia (Overeating) 10/2014
1	Exanthema (Rash) 11/2011
1	Mental Disorders (Mental Disorder) 11/2011
1	Dyskinesias (Dyskinesia) 05/2010
1	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 04/2010
1	Anemia 04/2008
1	Substance-Related Disorders (Drug Abuse) 05/2006
1	Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive) 04/2004
1	Schizophrenia (Dementia Praecox) 02/2004
1	Anorexia 02/2003

16	Dopamine (Intropin)FDA LinkGeneric 12/2015 - 02/2003
3	RacloprideIBA 06/2015 - 02/2003
3	Levodopa (L Dopa)FDA LinkGeneric 04/2011 - 04/2004
2	Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA 01/2019 - 01/2019
2	Cholinesterase Inhibitors (Anticholinesterases)IBA 03/2016 - 12/2013
2	Cholinergic Agents (Cholinergics)IBA 03/2016 - 12/2013
2	Rivastigmine (Exelon)FDA LinkGeneric 03/2016 - 12/2013
2	Dopamine Agents (Dopaminergic Agents)IBA 02/2013 - 05/2006
1	Dihydroxyphenylalanine (Dopa)IBA 01/2019
1	Type 4 Melanocortin Receptor (Melanocortin-4 Receptor)IBA 10/2014
1	Aminobutyrates (Aminobutyric Acid)IBA 11/2011
1	gamma-Aminobutyric Acid (GABA)IBA 11/2011
1	Dopamine D2 Receptors (Dopamine D2 Receptor)IBA 04/2011
1	Pharmaceutical PreparationsIBA 05/2010
1	Dopamine Agonists (Dopamine Agonist)IBA 04/2010
1	cobamamide (adenosylcobalamin)IBA 04/2008
1	Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric 04/2008
1	Coenzymes (Enzyme Cofactors)IBA 04/2008
1	fluorodopa F 18IBA 02/2004
1	Dopamine D2 Receptor AntagonistsIBA 12/2003
1	Sulpiride (neogama)IBA 12/2003